Synmosa Biopharma

Synmosa Biopharma was compromised in a ransomware attack attributed to dragonforce in April 2026. The organization, operating in the Healthcare sector in TW, was added to the group's data leak site as part of an extortion campaign.

dragonforce operates as a financially motivated ransomware-as-a-service (RaaS) operation, exfiltrating sensitive data and threatening public disclosure to pressure victims into paying ransom demands.

Synmosa is a specialty pharmaceutical corporation that engages in diversified development that includes acting as an agent, manufacturing, OEM, and R&D. Adhered...

Intelligence correlations link this incident to 1 vulnerability(ies) including CVE-2025-5777, which may have been leveraged as initial access vectors or for lateral movement.